← Back to Search
Treatment Patterns Among Patients With Malignant Pleural Mesothelioma: An Italian, Population‐based Nationwide Study
A. Trama, C. Proto, D. Signorelli, M. Garassino, G. Lo Russo, M. Ganzinelli, A. Prelaj, C. Mensi, Manuela Gangemi, V. Gennaro, E. Chellini, A. Caldarella, I. Angelillo, V. Ascoli, C. Pascucci, G. Tagliabue, R. Cusimano, F. Bella, F. Falcini, E. Merler, G. Masanotti, Antonio Ziino, M. Michiara, G. Gola, C. Storchi, L. Mangone, M. F. Vitale, C. Cirilli, R. Tumino, T. Scuderi, A. C. Fanetti, Silvano Piffer, M. Tiseo, G. Gatta, L. Botta
Published 2020 · Medicine
Download PDFAnalyze on Scholarcy
Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis. Centralization of rare cancer in dedicated centers is recommended to ensure expertise, multidisciplinarity and access to innovation. In Italy, expert centers for MPM have not been identified in all regions. We aimed to describe the treatment patterns among MPM patients across different Italian regions and to identify factors associated with the treatment patterns across the regions.
This paper references
A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
V. Rusch (1996)
Pleural mesothelioma incidence in Europe : Evidence of some deceleration in the increasing . ( Published erratum appears in Cancer Causes Control 2004 ; 15 : 103 . )
Malignant pleural mesothelioma: ESMO clinical practice guidelines
P Baas (2015)
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
S. Novello (2016)
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
E. Taioli (2015)
Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006.
P. Barbieri (2012)
Management and Survival of Pleural Mesothelioma: A Record Linkage Study
G. Carioli (2018)
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
V. Rusch (2016)
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population
R. Flores (2010)
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
R. Damhuis (2015)
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
Analysis of survival of mesothelioma cases in the Italian register (ReNaM).
A. Marinaccio (2003)
Treatment patterns and 1668 Thoracic Cancer
RA Damhuis (2020)
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
J. Beebe-Dimmer (2016)
Pleural mesothelioma incidence in Europe: Evidence of some deceleration in the increasing. (Published erratum appears in Cancer Causes Control
F Montanaro (2004)
The Italian Rare Cancer Network.
R. Sanfilippo (2012)
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
G. Ceresoli (2014)
Expert Opinions of the First Italian Consensus Conference on the Management of Malignant Pleural Mesothelioma
C. Pinto (2011)
Italian population by region and age
EORTC elderly task force position paper: approach to the older cancer patient.
A. Pallis (2010)
Networking in rare cancers: What was done, what's next.
A. Frezza (2019)
The Italian rare cancer
R Sanfilippo (2012)
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations.
C. Pinto (2013)
Patterns of care and survival among patients with malignant mesothelioma in the United States.
L. Enewold (2017)
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
G. Gatta (2017)
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends
F. Montanaro (2004)
The Mesothelioma epidemic in Western Europe: an update
C. Pelucchi (2004)
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients
V. Kovač (2012)
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections
C. Mensi (2016)
Clinical practice guidelines.
J. Wootton (1999)